For decades, members of the herbal medicine and conventional medical communities have debated the relative safety of herbs and phytomedicines as a class of consumer goods. Herbal advocates have generally stated that herbs and their medicinal preparations are relatively safe, as evidenced by low adverse events (AEs) in clinical trials, as well as infrequent reporting of AEs to poison control centers and other pharmacovigilance vehicles.
展开▼
